Patent details

Basic Information

Publication number:

EP1944322

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP071504427

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Treatment of TNF alpha related disorders

French Title of Invention:

Traitement des troubles associés au TND alpha

German Title of Invention:

Behandlung von Erkrankungen im Zusammenhang mit TNF-alpha

SPC Number:

Dates

Filing date:

18/07/2003

Grant date:

11/03/2015

EP Publication Date:

11/03/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/07/2008

EP B1 Publication Date:

11/03/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

18/07/2023

Renunciation date:

Revocation date:

02/12/2016

Annulment date:

Owner

From:

18/07/2003

 

 

Name:

AbbVie Biotechnology Ltd

Address:

Clarendon House 2, Church Street, HM 11 Hamilton, Bermuda (BM)

Agent

Name:

V.O. PATENTS & TRADEMARKS

From:

08/04/2015

Address:

PO Box 87930, 2508, DH The Hague, Netherlands (NL)

To:

Inventor

1

Name:

Murtaza Anwar

Address:

United States (US)

2

Name:

Spiegler Clive E.

Address:

United Kingdom (GB)

3

Name:

Salfeld Jochen, G.

Address:

United States (US)

4

Name:

Barchuk William T.

Address:

United States (US)

5

Name:

Chartash Eliot, Keith

Address:

United States (US)

6

Name:

Hoffman Rebecca S.

Address:

United States (US)

7

Name:

Banerjee Subhashis

Address:

United States (US)

8

Name:

Yan Philip

Address:

United States (US)

9

Name:

Tracey Daniel, Edward

Address:

United States (US)

10

Name:

Fischkoff Steven

Address:

United States (US)

11

Name:

Taylor Lori K.

Address:

United States (US)

Priority

1

Priority Number:

397275 P

Priority Date:

19/07/2002

Priority Country:

United States (US)

2

Priority Number:

411081 P

Priority Date:

16/09/2002

Priority Country:

United States (US)

3

Priority Number:

417490 P

Priority Date:

10/10/2002

Priority Country:

United States (US)

4

Priority Number:

455777 P

Priority Date:

18/03/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 16/24;

Publication

Bulletin

Bulletin Heading:

VRV

Bulletin edition number:

2017/02

Publication date:

22/06/2017

Description:

Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:

201715

Publication date:

12/04/2017

Description:

Revocation of the European patent

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

12/07/2016

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

MDC (HENKEL PATENT)

Filing date	Document type	Number of pages